InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,522.30
(
1.58%
)
US TECH 100
18,909.20
(
0.35%
)
Dow Jones
40,842.79
(
0.24%
)
Brent Oil
81.54
(
0.03%
)
Bitcoin
64,554.17
(
-0.06%
)
Post# of 690
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

levelnever

Send PM Follow Ignore
Followers 265
Posts 6831
Boards Moderated 3
Alias Born 07/28/2009

levelnever

Re: sharkey1 post# 344

Tuesday, 01/28/2020 11:33:47 AM

Tuesday, January 28, 2020 11:33:47 AM

Post# of 690
Yeah, I agree. If the number of cases grows then eventually Lannett will be needed and not by giveaway. Imagining supply of the drug will be stretched. Stumbled on LCI and wondered with all the other biotechs spiking, the only one that is producing a drug that is currently being used as treatment is not. Same so far with Abbvie, I think with giveaway like Gilead they are sending to test and see if it works.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up